1
|
Dudek K, Szacawa E, Nicholas RAJ. Recent Developments in Vaccines for Bovine Mycoplasmoses Caused by Mycoplasma bovis and Mycoplasma mycoides subsp. mycoides. Vaccines (Basel) 2021; 9:549. [PMID: 34073966 PMCID: PMC8225212 DOI: 10.3390/vaccines9060549] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 05/06/2021] [Accepted: 05/20/2021] [Indexed: 12/23/2022] Open
Abstract
Two of the most important diseases of cattle are caused by mycoplasmas. Mycoplasma bovis is a world-wide bovine pathogen that can cause pneumonia, mastitis and arthritis. It has now spread to most, if not all, cattle-rearing countries. Due to its increasing resistance to antimicrobial therapy, vaccination is the principal focus of the control of infection, but effective vaccines are currently lacking. Despite being eradicated from most parts of the world, Mycoplasma mycoides subsp. mycoides, the cause of contagious bovine pleuropneumonia (CBPP), continues to plague sub-Saharan Africa, affecting at least 25 countries. Numerous new experimental vaccines have been developed over the last 20 years to improve on protection afforded by the T1/44, a live vaccine in continuous use in Africa for over 60 years, but none so far have succeeded; indeed, many have exacerbated the disease. Tools for diagnosis and control are adequate for eradication but what is necessary are resources to improve vaccine coverage to levels last seen in the 1970s, when CBPP was restricted to a few countries in Africa. This paper summarizes the results of the main studies in the field of experimental mycoplasma vaccines, reviews data on commercially available bacterin vaccines and addresses issues relating to the search for new candidates for effective vaccines to reduce economic losses in the cattle industry caused by these two mycoplasmas.
Collapse
Affiliation(s)
- Katarzyna Dudek
- Department of Cattle and Sheep Diseases, National Veterinary Research Institute, 24100 Pulawy, Poland;
| | - Ewelina Szacawa
- Department of Cattle and Sheep Diseases, National Veterinary Research Institute, 24100 Pulawy, Poland;
| | | |
Collapse
|
2
|
Baseline analysis of Mycoplasma mycoides subsp. mycoides antigens as targets for a DIVA assay for use with a subunit vaccine for contagious bovine pleuropneumonia. BMC Vet Res 2020; 16:236. [PMID: 32650780 PMCID: PMC7350692 DOI: 10.1186/s12917-020-02453-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2020] [Accepted: 07/02/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Mycoplasma mycoides subsp. mycoides (Mmm) is the causative agent of contagious bovine pleuropneumonia in cattle. A prototype subunit vaccine is being developed, however, there is currently no diagnostic test that can differentiate between infected cattle and those vaccinated with the prototype subunit vaccine. This study characterized Mmm proteins to identify potential antigens for use in differentiating infected from vaccinated animals. RESULTS Ten Mmm antigens expressed as recombinant proteins were tested in an indirect ELISA using experimental sera from control groups, infected, and vaccinated animals. Data were imported into R software for analysis and drawing of the box and scatter plots while Cohen's Kappa assessed the level of agreement between the Mmm antigens. Two vaccine antigens (MSC_0499 and MSC_0776) were superior in detecting antibodies in sera of animals vaccinated with the subunit vaccines while two non-vaccine antigens (MSC_0636 and LppB) detected antibodies in sera of infected animals showing all clinical stages of the disease. Sensitivity and specificity of above 87.5% were achieved when the MSC_0499 and MSC_0636 antigens were tested on sera from vaccinated and infected animals. CONCLUSIONS The MSC_0499 and MSC_0776 antigens were the most promising for detecting vaccinated animals, while MSC_0636 and LppB were the best targets to identify infected animals. Further testing of sera from vaccinated and infected animals collected at different time intervals in the field should help establish how useful a diagnostic test based on a cocktail of these proteins would be.
Collapse
|
3
|
Liljander A, Sacchini F, Stoffel MH, Schieck E, Stokar-Regenscheit N, Labroussaa F, Heller M, Salt J, Frey J, Falquet L, Goovaerts D, Jores J. Reproduction of contagious caprine pleuropneumonia reveals the ability of convalescent sera to reduce hydrogen peroxide production in vitro. Vet Res 2019; 50:10. [PMID: 30736863 PMCID: PMC6368817 DOI: 10.1186/s13567-019-0628-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2018] [Accepted: 01/23/2019] [Indexed: 01/20/2023] Open
Abstract
Contagious caprine pleuropneumonia (CCPP), caused by Mycoplasma capricolum subsp. capripneumoniae is a severe disease widespread in Africa and Asia. Limited knowledge is available on the pathogenesis of this organism, mainly due to the lack of a robust in vivo challenge model and the means to do site-directed mutagenesis. This work describes the establishment of a novel caprine challenge model for CCPP that resulted in 100% morbidity using a combination of repeated intranasal spray infection followed by a single transtracheal infection employing the recent Kenyan outbreak strain ILRI181. Diseased animals displayed CCPP-related pathology and the bacteria could subsequently be isolated from pleural exudates and lung tissues in concentrations of up to 109 bacteria per mL as well as in the trachea using immunohistochemistry. Reannotation of the genome sequence of ILRI181 and F38T revealed the existence of genes encoding the complete glycerol uptake and metabolic pathways involved in hydrogen peroxide (H2O2) production in the phylogenetically related pathogen M. mycoides subsp. mycoides. Furthermore, the expression of L-α-glycerophosphate oxidase (GlpO) in vivo was confirmed. In addition, the function of the glycerol metabolism was verified by measurement of production of H2O2 in medium containing physiological serum concentrations of glycerol. Peroxide production could be inhibited with serum from convalescent animals. These results will pave the way for a better understanding of host-pathogen interactions during CCPP and subsequent vaccine development.
Collapse
Affiliation(s)
- Anne Liljander
- International Livestock Research Institute, Box 30709, Nairobi, 00100, Kenya
| | - Flavio Sacchini
- International Livestock Research Institute, Box 30709, Nairobi, 00100, Kenya.,Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Länggass-Str. 122, Postfach, 3001, Bern, Switzerland.,Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", via Campo Boario, 64100, Teramo, Italy
| | - Michael H Stoffel
- Division of Veterinary Anatomy, Vetsuisse Faculty, University of Bern, Länggass-Str. 120, Postfach, 3001, Bern, Switzerland
| | - Elise Schieck
- International Livestock Research Institute, Box 30709, Nairobi, 00100, Kenya
| | - Nadine Stokar-Regenscheit
- Institute of Animal Pathology (COMPATH), Vetsuisse Faculty, University of Bern, Länggass-Str. 122, Postfach, 3001, Bern, Switzerland
| | - Fabien Labroussaa
- Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Länggass-Str. 122, Postfach, 3001, Bern, Switzerland
| | - Martin Heller
- Friedrich-Loeffler-Institute-Federal Research Institute for Animal Health, Naumburger Str. 96a, 07743, Jena, Germany
| | - Jeremy Salt
- GALVmed, Doherty Building, Pentlands Science Park, Bush Loan, Penicuik, Edinburgh, EH26 0PZ, Scotland, UK
| | - Joachim Frey
- Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Länggass-Str. 122, Postfach, 3001, Bern, Switzerland
| | - Laurent Falquet
- Division of Biochemistry, Department of Biology, University of Fribourg and Swiss Institute of Bioinformatics, Chemin du Musée 18, 1700, Fribourg, Switzerland
| | - Danny Goovaerts
- GALVmed, Doherty Building, Pentlands Science Park, Bush Loan, Penicuik, Edinburgh, EH26 0PZ, Scotland, UK
| | - Joerg Jores
- International Livestock Research Institute, Box 30709, Nairobi, 00100, Kenya. .,Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Länggass-Str. 122, Postfach, 3001, Bern, Switzerland.
| |
Collapse
|
4
|
Gaurivaud P, Ganter S, Villard A, Manso-Silvan L, Chevret D, Boulé C, Monnet V, Tardy F. Mycoplasmas are no exception to extracellular vesicles release: Revisiting old concepts. PLoS One 2018; 13:e0208160. [PMID: 30485365 PMCID: PMC6261642 DOI: 10.1371/journal.pone.0208160] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2018] [Accepted: 11/13/2018] [Indexed: 12/12/2022] Open
Abstract
Release of extracellular vesicles (EV) by Gram-negative and positive bacteria is being frequently reported. EV are nano-sized, membrane-derived, non-self-replicating, spherical structures shed into the extracellular environment that could play a role in bacteria-host interactions. Evidence of EV production in bacteria belonging to the class Mollicutes, which are wall-less, is mainly restricted to the genus Acholeplasma and is scanty for the Mycoplasma genus that comprises major human and animal pathogens. Here EV release by six Mycoplasma (sub)species of clinical importance was investigated. EV were obtained under nutritional stress conditions, purified by ultracentrifugation and observed by electron microscopy. The membrane proteins of EV from three different species were further identified by mass spectrometry as a preliminary approach to determining their potential role in host-pathogen interactions. EV were shown to be released by all six (sub)species although their quantities and sizes (30-220 nm) were very variable. EV purification was complicated by the minute size of viable mycoplasmal cells. The proteins of EV-membranes from three (sub)species included major components of host-pathogen interactions, suggesting that EV could contribute to make the host-pathogen interplay more complex. The process behind EV release has yet to be deciphered, although several observations demonstrated their active release from the plasma membrane of living cells. This work shed new light on old concepts of "elementary bodies" and "not-cell bound antigens".
Collapse
Affiliation(s)
- Patrice Gaurivaud
- Université de Lyon, Anses, Laboratoire de Lyon, UMR Mycoplasmoses des Ruminants, Lyon, France
- Université de Lyon, VetAgro Sup, UMR Mycoplasmoses des Ruminants, Marcy-L’étoile, France
- * E-mail:
| | - Sarah Ganter
- Université de Lyon, Anses, Laboratoire de Lyon, UMR Mycoplasmoses des Ruminants, Lyon, France
- Université de Lyon, VetAgro Sup, UMR Mycoplasmoses des Ruminants, Marcy-L’étoile, France
| | - Alexandre Villard
- Université de Lyon, Anses, Laboratoire de Lyon, UMR Mycoplasmoses des Ruminants, Lyon, France
- Université de Lyon, VetAgro Sup, UMR Mycoplasmoses des Ruminants, Marcy-L’étoile, France
| | - Lucia Manso-Silvan
- CIRAD, UMR ASTRE, Montpellier, France
- INRA, UMR ASTRE, Montpellier, France
| | - Didier Chevret
- PAPPSO, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France
| | - Christelle Boulé
- Université Claude Bernard Lyon 1, Centre Technologique des Microstructures, Service « Etudes à façon » EZUS Lyon, Villeurbanne, France
| | - Véronique Monnet
- PAPPSO, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France
| | - Florence Tardy
- Université de Lyon, Anses, Laboratoire de Lyon, UMR Mycoplasmoses des Ruminants, Lyon, France
- Université de Lyon, VetAgro Sup, UMR Mycoplasmoses des Ruminants, Marcy-L’étoile, France
| |
Collapse
|
5
|
Kama-Kama F, Omosa LK, Nganga J, Maina N, Osanjo G, Yaouba S, Ilias M, Midiwo J, Naessens J. Antimycoplasmal Activities of Compounds from Solanum aculeastrum and Piliostigma thonningii against Strains from the Mycoplasma mycoides Cluster. Front Pharmacol 2017; 8:920. [PMID: 29311927 PMCID: PMC5742823 DOI: 10.3389/fphar.2017.00920] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 12/04/2017] [Indexed: 11/22/2022] Open
Abstract
Infections caused by Mycoplasma species belonging to the ‘mycoides cluster’ negatively affect the agricultural sector through losses in livestock productivity. These Mycoplasma strains are resistant to many conventional antibiotics due to the total lack of cell wall. Therefore, there is an urgent need to develop new antimicrobial agents from alternative sources such as medicinal plants to curb the resistance threat. Recent studies on extracts from Solanum aculeastrum and Piliostigma thonningii revealed interesting antimycoplasmal activities hence the motivation to investigate the antimycoplasmal activities of constituent compounds. The CH2Cl2/MeOH extracts from the berries of S. aculeastrum yielded a new β-sitosterol derivative (1) along with six known ones including; lupeol (2), two long-chain fatty alcohols namely undecyl alcohol (3) and lauryl alcohol (4); two long-chain fatty acids namely; myristic acid (5) and nervonic acid (6) as well as a glycosidic steroidal alkaloid; (25R)-3β-O-α-L-rhamnopyranosyl-(1→2)-O-[α-L-rhamnopyranosyl-(1→4)]-β-D-glucopyranosyloxy-22α-N-spirosol-5-ene (7) from the MeOH extracts. A new furan diglycoside, (2,5-D-diglucopyranosyloxy-furan) (8) was also characterized from the CH2Cl2/MeOH extract of stem bark of P. thonningii. The structures of the compounds were determined on the basis of spectroscopic evidence and comparison with literature data. Compounds 1, 3, 4, 7, and 8 isolated in sufficient yields were tested against the growth of two Mycoplasma mycoides subsp. mycoides (Mmm), two M. mycoides. capri (Mmc), and one M. capricolum capricolum (Mcc) using broth dilution methods, while the minimum inhibitory concentration (MIC) was determined by serial dilution. The inhibition of Mycoplasma in vitro growth was determined by the use of both flow cytometry (FCM) and color change units (CCU) methods. Compounds 4 and 7 showed moderate activity against the growth of Mmm and Mmc but were inactive against the growth of Mcc. The lowest MIC value was 50 μg/ml for compound 7 against Mmm. The rest of the compounds showed minimal or no activity against the strains of Mycoplasma mycoides tested. This is the first report on the use of combined FCM and CCU to determine inhibition of in vitro growth of Mycoplasma mycoides. The activity of these compounds against other bacterial strains should be tested and their safety profiles determined.
Collapse
Affiliation(s)
- Francisca Kama-Kama
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.,Biosciences Eastern and Central Africa, International Livestock Research Institute, Nairobi, Kenya
| | | | - Joseph Nganga
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| | - Naomi Maina
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| | - Georges Osanjo
- Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi, Kenya
| | - Souaibou Yaouba
- Department of Chemistry, University of Nairobi, Nairobi, Kenya
| | - Muhammad Ilias
- National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, Oxford, MS, United States
| | - Jacob Midiwo
- Department of Chemistry, University of Nairobi, Nairobi, Kenya
| | - Jan Naessens
- Biosciences Eastern and Central Africa, International Livestock Research Institute, Nairobi, Kenya
| |
Collapse
|
6
|
Kama-Kama F, Midiwo J, Nganga J, Maina N, Schiek E, Omosa LK, Osanjo G, Naessens J. Selected ethno-medicinal plants from Kenya with in vitro activity against major African livestock pathogens belonging to the "Mycoplasma mycoides cluster". JOURNAL OF ETHNOPHARMACOLOGY 2016; 192:524-534. [PMID: 27649681 PMCID: PMC5081062 DOI: 10.1016/j.jep.2016.09.034] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2016] [Revised: 08/23/2016] [Accepted: 09/16/2016] [Indexed: 05/23/2023]
Abstract
ETHNOPHARMOCOLOGICAL RELEVANCE Members of 'Mycoplasma mycoides cluster' are important ruminant pathogens in Africa. Diseases caused by these Mycoplasma negatively affect the agricultural sector especially in developing countries through losses in livestock productivity, mortality and international trade restrictions. There is therefore urgent need to develop antimicrobials from alternative sources such as medicinal plants to curb these diseases. In Kenya, smallholder farmers belonging to the Maasai, Kuria and Luo rely on traditional Kenyan herbals to treat respiratory symptoms in ruminants. In the current study extracts from some of these plants were tested against the growth of members of Mycoplasma mycoides cluster. AIM This study aimed at identifying plants that exhibit antimycoplasmal activities using an ethnobotanical approach. MATERIALS AND METHODS Kenyan farmers of Maasai, Luo and Kuria ethnic groups were interviewed for plant remedies given to livestock with respiratory syndromes. The plant materials were thereafter collected and crude extracts prepared using a mixture of 50% of methanol (MeOH) in dichloromethane (CH2Cl2), neat methanol (MeOH), ethanol (EtOH) and water to yield four crude extracts per plant part. The extracts were tested in vitro against five strains of Mycoplasma mycoides subsp. capri, five strains of Mycoplasma mycoides subsp. mycoides and one strain of Mycoplasma capricolum subsp capricolum using broth micro-dilution assays with an initial concentration of 1mg/ml. Minimum inhibitory concentration (MIC) of the most active extracts were determined by serial dilution. RESULTS Extracts from five plants namely: Solanum aculeastrum, Albizia coriaria, Ekebergia capensis, Piliostigma thonningii and Euclea divinorum exhibited the highest activities against the Mycoplasma strains tested. Mycoplasma mycoides subsp. mycoides were more susceptible to these extracts than Mycoplasma mycoides subsp. capri and Mycoplasma capricolum susp. capricolum. The activities of the crude extracts varied with the solvent used for extraction. The MICs mean values of the active extracts varied from 0.02 to 0.6mg/ml. CONCLUSIONS The results suggested that these plants could potentially contain antimicrobial compounds that might be useful for the treatment of respiratory diseases in ruminants. Future work should focus on the isolation and identification of the active compounds from the plant extracts that showed interesting activities and evaluation of their antimicrobial and cytotoxic potential.
Collapse
Affiliation(s)
- Francisca Kama-Kama
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000, Nairobi, Kenya; Biosciences Eastern & Central Africa - International Livestock Research Institute, Old Naivasha Road, PO Box 30709, 00100 Nairobi, Kenya.
| | - Jacob Midiwo
- Department of Chemistry, School of Physical Sciences, University of Nairobi, P.O Box 30197, Nairobi, Kenya
| | - Joseph Nganga
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000, Nairobi, Kenya
| | - Naomi Maina
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000, Nairobi, Kenya
| | - Elise Schiek
- Biosciences Eastern & Central Africa - International Livestock Research Institute, Old Naivasha Road, PO Box 30709, 00100 Nairobi, Kenya
| | - Leonidah Kerubo Omosa
- Department of Chemistry, School of Physical Sciences, University of Nairobi, P.O Box 30197, Nairobi, Kenya
| | - George Osanjo
- Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, P.O Box 30197, Nairobi, Kenya
| | - Jan Naessens
- Biosciences Eastern & Central Africa - International Livestock Research Institute, Old Naivasha Road, PO Box 30709, 00100 Nairobi, Kenya.
| |
Collapse
|
7
|
Mwirigi M, Nkando I, Olum M, Attah-Poku S, Ochanda H, Berberov E, Potter A, Gerdts V, Perez-Casal J, Wesonga H, Soi R, Naessens J. Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia. Vet Immunol Immunopathol 2016; 178:64-9. [PMID: 27496744 DOI: 10.1016/j.vetimm.2016.07.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2016] [Revised: 06/27/2016] [Accepted: 07/02/2016] [Indexed: 10/21/2022]
Abstract
Contagious Bovine Pleuropneumonia (CBPP) is a severe respiratory disease caused by Mycoplasma mycoides subsp. mycoides (Mmm) which is widespread in Africa. The capsule polysaccharide (CPS) of Mmm is one of the few identified virulence determinants. In a previous study, immunization of mice against CPS generated antibodies, but they were not able to prevent multiplication of Mmm in this model animal. However, mice cannot be considered as a suitable animal model, as Mmm does not induce pathology in this species. Our aim was to induce antibody responses to CPS in cattle, and challenge them when they had specific CPS antibody titres similar or higher than those from cattle vaccinated with the live vaccine. The CPS was linked to the carrier protein ovalbumin via a carbodiimide-mediated condensation with 1-ethyl-3(3-imethylaminopropyl) carbodiimide (EDC). Ten animals were immunized twice and challenged three weeks after the booster inoculation, and compared to a group of challenged non-immunized cattle. When administered subcutaneously to adult cattle, the vaccine elicited CPS-specific antibody responses with the same or a higher titre than animals vaccinated with the live vaccine. Pathology in the group of immunized animals was significantly reduced (57%) after challenge with Mmm strain Afadé compared to the non-immunized group, a figure in the range of the protection provided by the live vaccine.
Collapse
Affiliation(s)
- Martin Mwirigi
- Kenya Agricultural and Livestock Research Organization, Biotechnology Research Institute, P.O. Box 14733, 00800, Nairobi, Kenya.
| | - Isabel Nkando
- Kenya Agricultural and Livestock Research Organisation, Veterinary Science Research Institute, P.O. Box 32, 00902, Kikuyu, Kenya
| | - Moses Olum
- University of Nairobi, P.O. Box 30197, Nairobi, Kenya
| | - Samuel Attah-Poku
- Vaccine and Infectious Disease Organization - International Vaccine Centre, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, SK, S7N 5E3, Canada
| | | | - Emil Berberov
- Vaccine and Infectious Disease Organization - International Vaccine Centre, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, SK, S7N 5E3, Canada
| | - Andrew Potter
- Vaccine and Infectious Disease Organization - International Vaccine Centre, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, SK, S7N 5E3, Canada
| | - Volker Gerdts
- Vaccine and Infectious Disease Organization - International Vaccine Centre, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, SK, S7N 5E3, Canada
| | - Jose Perez-Casal
- Vaccine and Infectious Disease Organization - International Vaccine Centre, University of Saskatchewan, 120 Veterinary Rd., Saskatoon, SK, S7N 5E3, Canada
| | - Hezron Wesonga
- Kenya Agricultural and Livestock Research Organisation, Veterinary Science Research Institute, P.O. Box 32, 00902, Kikuyu, Kenya
| | - Reuben Soi
- Kenya Agricultural and Livestock Research Organization, Biotechnology Research Institute, P.O. Box 14733, 00800, Nairobi, Kenya
| | - Jan Naessens
- International Livestock Research Institute, P.O. Box 30709, 00100, Nairobi, Kenya
| |
Collapse
|
8
|
Development of a Novel Cocktail Enzyme-Linked Immunosorbent Assay and a Field-Applicable Lateral-Flow Rapid Test for Diagnosis of Contagious Bovine Pleuropneumonia. J Clin Microbiol 2016; 54:1557-1565. [PMID: 27053669 DOI: 10.1128/jcm.03259-15] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2015] [Accepted: 03/17/2016] [Indexed: 11/20/2022] Open
Abstract
Contagious bovine pleuropneumonia (CBPP) is a severe respiratory disease that is widespread in sub-Saharan Africa. It is caused by Mycoplasma mycoides subsp. mycoides, a bacterium belonging to the Mycoplasma mycoides cluster. In the absence of an efficient CBPP vaccine, improved and easy-to-use diagnostic assays for recurrent testing combined with isolation and treatment of positive animals represent an option for CBPP control in Africa. Here we describe the comprehensive screening of 17 immunogenic Mycoplasma mycoides subsp. mycoides proteins using well-characterized bovine sera for the development of a novel cocktail enzyme-linked immunosorbent assay (ELISA) for laboratory use. Two recombinant Mycoplasma immunogens, MSC_0136 and MSC_0636, were used to set up a standardized cocktail ELISA protocol. According to the results from more than 100 serum samples tested, the sensitivity and specificity of the novel cocktail ELISA were 85.6% and 96.4%, respectively, with an overall diagnostic accuracy comparable to that of the Office International des Epizooties (OIE)-prescribed serological assays. In addition, we provide a proof of principle for a field-applicable, easy-to-use commercially produced prototype lateral-flow test for rapid (<30-min) diagnosis of CBPP.
Collapse
|